About Illumina, Inc. |
Illumina, Inc. Innovation is in our genes. Illumina (NASDAQ: ILMN) develops next-generation tools for large-scale analysis of genetic variation and function. The results will pave the way for personalized medicine, a key goal of genomics and proteomics - the underpinnings of tomorrow's medicine. With thought-provoking work and people inspired to reach new levels of creativity, the potential to help mankind is the great motivator for the staff at Illumina. We thrive on an environment that is intellectually stimulating, team-oriented and responsive. We enjoy cutting-edge technology, excellent training, industry-leading benefits, and a strong belief in ethical behavior - and each other. Oh, and fun. Lots of it. Illumina is the life sciences company developing genome-wide technologies for genotyping, gene expression and sequencing-the three cornerstones of modern genetic analysis. By enabling studies of thousands of patient samples at once, our products set genetic discovery on fast forward. And we're just getting started. Illumina offers the best in careers for forward-thinking individuals. To learn more, visit:www.illumina.com/careers
